MarkBHazukaMD

PubMed

• 259 citations
  Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
  Mary K. Martel, Randall K. Ten Haken, Mark B. Hazuka, Marc L. Kessler, Myla Strawderman
  Lung Cancer. 1999-04-01
• 11 citations
  A PHASE I STUDY OF DAILY CARBOPLATIN AND SIMULTANEOUS ACCELERATED, HYPERFRACTIONATED CHEST IRRADIATION IN PATIENTS WITH REGIONALLY INOPERABLE NON-SMALL CELL LUNG CANCER
  Karen Kelly, Mark Hazuka, Zhaozing Pan, James E. Murphy, Jennifer Caskey
  International Journal of Radiation Oncology, Biology, Physics. 1998-02-01
• 51 citations
  Volume and dose parameters for survival of non-small cell lung cancer patients
  Mary K. Martel, Myla Strawderman, Mark B. Hazuka, Andrew T. Turrisi, Benedick A. Fraass
  Radiotherapy and Oncology. 1997-07-01

Books/Book Chapters

• Lung Cancer. 
  Chapter: Combined chemotherapy and radiotherapy in the nonsurgical treatment of stage III non-small cell lung cancer. 
  Page 231 - 245Hazuka MB, Gandara DR and Turrisi ATEditors: Johnson B and Johnson DH.John Wiley & Sons, Inc., New York, NY1995
• Lung Cancer: Principles and Practice. 
  Chapter: Three-dimensional treatment planning in lung cancer radiotherapy. 
  Page 685 - 696Rosenman J, Hazuka MB, and Martel MKEditors: Pass HI, Mitchell J, Johnson DH, and Turrisi AT.J.B. Lippincott Company, Philadelphia, PA1995
• 3-D Radiation Treatment Planning and Comformal Therapy - Proceedings of an International Symposium, April 21-23, 1993. 
  Chapter: 3D-RTP The University of Michigan Experience. 
  Page 95 - 104Lawrence TS, Ten Haken RK, Sandler HM, Hazuka MB, Robertson JM, Martel MK, Kessler ML, Turrisi AT, Fraass BA and Lichter ASMedical Physics, Madison, WI1995
• Lung Cancer Frontiers in Science and Treatment. 
  Chapter: Neoadjuvant therapy in locally advanced lung cancer: a perspective from radiation oncology. 
  Page 645 - 655Hazuka MB, and Turrisi AT IIIEditors: Motta G.Grafica L.P., Genoa, Italy1994
• Current Genitourinary Cancer Surgery. 
  Chapter: Palliative irradiation for genitourinary carcinoma. 
  Page 572 - 580Hazuka MBEditors: Crawford DE and Das S.Lea & Febiger, Philadelphia, PA1990
• Join now to see all

Abstracts/Posters

• A new approach to the prevention of radiation-induced skin desquamation using a polymer adhesive skin sealant (PASS): final results of a prospective study.
  Hazuka MB and Goebel RH, Proc Am Soc Clin Oncol, 1/1/1997
• Dose Escalation for Non-Small Cell Lung Cancer Using Conformal Radiation Therapy.
  Robertson JM, Turrisi AT, Hazuka MB, Martel MK, Ten Haken RK, Littles JF, Martinez FJ, Lichter AS, Int J Radiat Oncol Biol Phys, 1/1/1995
• 3-D dose distribution analysis for visual pathway structures for patients with advanced paranasal sinus tumors.
  Martel MK, Sandler HM, Cornblath WT, Marsh LH, Hazuka MB, Roa WH, Fraass BA, Int J Radiat Oncol Biol Phys, 1/1/1995
• A Phase I-II Trial of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation (CRT) followed by carboplatin in patients with regionally ino...
  Kelly K, Bunn PA Jr, Hazuka MB, Turrisi A, Leonard C, and Caskey J, Proc Am Soc Clin Oncol, 1/1/1995
• Estimation of tumor control probability model parameters from a database of 3-D dose distributions of non- small cell lung cancer patients.
  Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Turrisi AT and Fraass BA, Lung Cancer, 1/1/1994
• Dose-escalation in non-small cell lung cancer (NSCLC) using conformal 3-dimensional radiation treatment planning (3DRTP): Preliminary results of a Phase I study.
  Hazuka MB, Turrisi III AT, Martel MK, Ten Haken RK, Littles JF, Lichter AS and Fraass BA, Proc Am Soc Clin Oncol, 1/1/1994
• Dose-escalation in non-small cell lung cancer (NSCLC) using conformal 3-dimensional radiation treatment planning (3DRTP): Preliminary results of a Phase I study.
  Hazuka MB, Turrisi III AT, Martel MK, Ten Haken RK, Littles JF, Lichter AS and Fraass BA, Lung Cancer, 1/1/1994
• Re-Irradiation of non-small cell lung cancer.
  Littles JF, Turrisi AT, Hazuka MB, Massey V, and Martel M, Lung Cancer, 1/1/1994
• A Phase I-II study of daily carboplatin and simultaneously accelerated, hyperfactionated chest irradiation followed by carboplatin in patients with regionally inoperab...
  Kelly K, Bunn Jr. DA, Hazuka MB, and Turrisi AT, Lung Cancer, 1/1/1994
• Dose-escalation in non-small cell lung cancer using 3-dimensional radiation treatment planning.
  Hazuka MB, Turrisi III AT, Martel MK, and Ten Haken RK, Lung Cancer, 1/1/1994
• Concurrent daily low-dose cisplatin plus high-dose thoracic irradiation (RT) in locally advanced non-small cell lung cancer (NSCLC): Report of a Southwest Oncology Gro...
  Hazuka MB, Crowley J. Bunn, Jr.PA, IASLC Workshop, Bruge, Belgium, 1/1/1993
• Assessment of liver and lung motion for conformal therapy using radiopaque markers.
  Ten Haken RK, Lam KL, Balter JM, Robertson JM, Hazuka MB, Andrews JC, Medical Physics, 1/1/1993
• Analysis of tumor dose-volume histograms in relationship to local progression free survival for lung cancer patients.
  Martel MK, Ten Haken RK, Hazuka MB, Kessler ML and Turrisi AT, Int J Radiat Oncol Biol Phys, 1/1/1993
• NTCP lung model parameter adjustment based on clinical 3-D dose-volume data.
  Ten Haken RK, Martel MK, Hazuka MB, Kessler ML and Turrisi AT, Int J Radiat Oncol Biol Phys, 1/1/1993
• Preservation of vision after radiation therapy for advanced tumors of the paranasal sinus: Preliminary clinical results using CT-based 3-dimensional treatment planning.
  Roa WHY, Hazuka MB, Martel MK, Sandler HM, Thornton AF, Turrisi AT, Urba S, Wolf GT and Lichter AS:, Int J Radiat Oncol Biol Phys, 1/1/1993
• Neoadjuvant therapy in locally advanced lung cancer: a perspective from radiation oncology.
  Turrisi AT and Hazuka MB, New Frontiers in Lung Cancer International Meeting, 1/1/1993
• The role of alpha interferon (rINFa2a) maintenance in patients with limited stage SCLC responding to concurrent chemoradiation: A Southwest Oncology Study (SWOG).
  Kelly K, Bunn, Jr. PA, Hazuka MB, Beasley K, Crowley J and Livingston R, Proc Am Soc Clin Oncol, 1/1/1993
• Results of high dose thoracic irradiation (RT) using computed tomography (CT)-based treatment planning and beams eye view (BEV) display in non-small cell lung cancer (...
  Hazuka MB, Lutz ST, Turrisi AT, Martel MK, Ten Haken RK, Borema LP and Lichter AS, Int J Radiat Oncol Biol Phys, 1/1/1992
• Dose-volume histogram and 3-D/CT treatment planning evaluation of patients with radiation pneumonitis.
  Martel MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA and Lichter AS, Int J Radiat Oncol Biol Phys, 1/1/1992
• Use of Veff and ISO-NTCP in the design of dose escalation protocols.
  Ten Haken RK, Martel MK, Hazuka MB, Lawrence TS, Turrisi AT and Lichter AS, Int J Radiat Oncol Biol Phys, 1/1/1992
• Concurrent daily low-dose cisplatin (LDCP) combined with chest irradiation (RT) in locally advanced non-small cell lung cancer: Preliminary results of a Southwest Onco...
  Hazuka MB, Crowley JA and Livingston R, Proc Am Soc Clin Oncol, 1/1/1992
• The role of GM-CSF in limited stage SCLC: A randomized phase III study of the Southwest Oncology Group (SWOG).
  Bunn, Jr.PA, Crowley J, Hazuka MB, Tolley R and Livingston RB, Proc Am Soc Clin Oncol, 1/1/1992
• Inflammatory breast cancer (IBC) treated with combined modality therapy.
  Leonard C, Hazuka MB, Sedlacek S and Norton L, Int J Radiat Oncol Biol Phys, 1/1/1991
• Inflammatory breast cancer (IBC) treated with combined modality therapy.
  Hazuka MB, Leonard C, Sedlacek S and Norton L, Proc Am Soc Clin Oncol, 1/1/1991
• Suitability of commonly available inhomogeneity correction algorithms for photon beams passing through high density prosthetic materials.
  Stroud DN, Hazuka MB, Burleson WD, Cofran K and Newman F, Radiology, 1/1/1991
• Join now to see all